MBNL1 and myotonic dystrophy type 1: Together, these results display reproducible results for boldine activity on different early molecular and cellular DM1 features in different disease models, with an ability to reduce ribonuclear foci, but not connect to a relocation of a functional MBNL1 or AS modulation.